PPARG and ulcerative colitis: This study demonstrated that PPARγ can act as a tumor suppressor in vivo and when its normal activityis altered it can lead to cancer development [29].Subsequent studies have confirmed these results showing the reduction of PPARγ expression in both acrometaly [30]and ulcerative colitis [31],two predisposing conditions of colon cancer.